Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prokidney (PROK) Shares Outstanding (2022 - 2025)

Prokidney (PROK) has disclosed Shares Outstanding for 4 consecutive years, with $159.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 24.52% to $159.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $159.3 million, a 24.52% increase, with the full-year FY2024 number at $128.1 million, down 23.91% from a year prior.
  • Shares Outstanding was $136.0 million for Q3 2025 at Prokidney, up from $133.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $186.5 million in Q1 2022 to a low of $61.6 million in Q2 2023.
  • A 4-year average of $139.2 million and a median of $134.7 million in 2025 define the central range for Shares Outstanding.
  • Biggest YoY gain for Shares Outstanding was 182.48% in 2023; the steepest drop was 66.98% in 2023.
  • Prokidney's Shares Outstanding stood at $171.6 million in 2022, then decreased by 1.91% to $168.3 million in 2023, then fell by 23.91% to $128.1 million in 2024, then rose by 24.39% to $159.3 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Shares Outstanding are $159.3 million (Q3 2025), $159.3 million (Q2 2025), and $129.5 million (Q1 2025).